Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor.

PubWeight™: 1.96‹?› | Rank: Top 2%

🔗 View Article (PMC 46163)

Published in Proc Natl Acad Sci U S A on April 01, 1993

Authors

J Fantini1, D G Cook, N Nathanson, S L Spitalnik, F Gonzalez-Scarano

Author Affiliations

1: Department of Neurology, University of Pennsylvania Medical Center, Philadelphia 19104-6146.

Articles citing this

A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J Virol (1996) 3.26

Virus receptors: binding, adhesion strengthening, and changes in viral structure. J Virol (1994) 2.92

Virus entry, assembly, budding, and membrane rafts. Microbiol Mol Biol Rev (2003) 2.68

Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol (1995) 2.24

CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am J Pathol (1997) 2.00

Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane. EMBO J (1994) 1.99

Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med (1996) 1.75

Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence. J Virol (1996) 1.74

Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype. J Virol (1998) 1.69

HIV binding, penetration, and primary infection in human cervicovaginal tissue. Proc Natl Acad Sci U S A (2005) 1.67

Role of mannose-6-phosphate receptors in herpes simplex virus entry into cells and cell-to-cell transmission. J Virol (1995) 1.58

Use of a novel human immunodeficiency virus type 1 reporter virus expressing human placental alkaline phosphatase to detect an alternative viral receptor. J Virol (1995) 1.51

The majority of cells are superinfected in a cloned cell line that produces high levels of human immunodeficiency virus type 1 strain MN. J Virol (1995) 1.34

Rapid dissemination of SIV follows multisite entry after rectal inoculation. PLoS One (2011) 1.24

Presence of host ICAM-1 in human immunodeficiency virus type 1 virions increases productive infection of CD4+ T lymphocytes by favoring cytosolic delivery of viral material. J Virol (2003) 1.24

Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection. Immunology (2003) 1.23

Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids. PLoS One (2011) 1.10

Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells. J Virol (2001) 1.08

Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins. J Virol (1995) 1.08

The Role of Lipids in Retrovirus Replication. Viruses (2010) 1.07

How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer's beta amyloid peptide (Abeta1-40). PLoS One (2010) 1.07

Infection of semen-producing organs by SIV during the acute and chronic stages of the disease. PLoS One (2008) 1.07

Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region. J Immunol (2007) 1.06

Glycosphingolipid functions. Cold Spring Harb Perspect Biol (2011) 1.02

Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1994) 1.00

Sphingolipid-dependent fusion of Semliki Forest virus with cholesterol-containing liposomes requires both the 3-hydroxyl group and the double bond of the sphingolipid backbone. J Virol (1995) 0.99

Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants. Retrovirology (2013) 0.98

Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell line. J Virol (1995) 0.98

Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide. J Virol (1994) 0.96

Notch ligand activity is modulated by glycosphingolipid membrane composition in Drosophila melanogaster. J Cell Biol (2010) 0.96

HIV-particles in spermatozoa of patients with AIDS and their transfer into the oocyte. J Cell Biol (1994) 0.95

Squalamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria? PLoS One (2008) 0.95

Galactosylceramide domain microstructure: impact of cholesterol and nucleation/growth conditions. Biophys J (2006) 0.94

Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line. J Virol (1995) 0.94

Human immunodeficiency virus type 1 infection and replication in normal human oral keratinocytes. J Virol (2003) 0.94

Porcine 987P glycolipid receptors on intestinal brush borders and their cognate bacterial ligands. Infect Immun (1996) 0.94

Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection. Biochem J (1996) 0.93

The role of glycosphingolipids in HIV signaling, entry and pathogenesis. Glycoconj J (2004) 0.92

Porphyromonas gingivalis induces CCR5-dependent transfer of infectious HIV-1 from oral keratinocytes to permissive cells. Retrovirology (2008) 0.92

gp340 promotes transcytosis of human immunodeficiency virus type 1 in genital tract-derived cell lines and primary endocervical tissue. J Virol (2009) 0.92

A major fraction of glycosphingolipids in model and cellular cholesterol-containing membranes is undetectable by their binding proteins. J Biol Chem (2010) 0.90

Different regions of HIV-1 subtype C env are associated with placental localization and in utero mother-to-child transmission. J Virol (2011) 0.89

Fluid-phase chain unsaturation controlling domain microstructure and phase in ternary lipid bilayers containing GalCer and cholesterol. Biophys J (2007) 0.88

Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: activation of signal transduction pathways and perturbations of intestinal absorption and secretion. Glycoconj J (2001) 0.87

Inactivation of human immunodeficiency virus type 1 by porphyrins. Antimicrob Agents Chemother (2002) 0.85

Activation by inflammatory stimuli increases neutrophil binding of human immunodeficiency virus type 1 and subsequent infection of lymphocytes. J Virol (2004) 0.85

Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors. J Lipid Res (2010) 0.83

Human immunodeficiency virus type 1 gp120 stimulates cytomegalovirus replication in monocytes: possible role of endogenous interleukin-8. J Virol (1997) 0.82

Function of membrane rafts in viral lifecycles and host cellular response. Biochem Res Int (2011) 0.82

Domain nucleation rates and interfacial line tensions in supported bilayers of ternary mixtures containing galactosylceramide. Biophys J (2007) 0.79

HIV-1 infection is facilitated in T cells by decreasing p56lck protein tyrosine kinase activity. Clin Exp Immunol (2003) 0.79

Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection. Antimicrob Agents Chemother (2004) 0.79

Infection of SK-N-MC cells, a CD4-negative neuroblastoma cell line, with primary human immunodeficiency virus type 1 isolates. J Virol (1996) 0.78

Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide. J Virol (2014) 0.77

Differential effect of the immunomodulatory hormone somatostatin on replication of human immunodeficiency virus type 1 in CD4+ and CD8+ T lymphocytes. Clin Diagn Lab Immunol (1995) 0.77

Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens. Antiviral Res (2016) 0.75

Articles cited by this

Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science (1984) 33.32

An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol (1992) 4.85

Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med (1984) 3.22

Animal glycosphingolipids as membrane attachment sites for bacteria. Annu Rev Biochem (1989) 3.22

Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types. J Exp Med (1989) 3.22

Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci U S A (1982) 3.21

Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet (1988) 3.21

Gangliosides: structure, isolation, and analysis. Methods Enzymol (1982) 3.20

Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J Virol (1987) 2.84

CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J Virol (1989) 2.77

Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science (1991) 2.77

Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. Proc Natl Acad Sci U S A (1989) 2.66

Mechanism of HIV spread from lymphocytes to epithelia. Virology (1992) 1.99

Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann Intern Med (1989) 1.99

Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1991) 1.80

AIDS enteropathy. Clin Infect Dis (1992) 1.76

Structures of blood group glycosphingolipids of human small intestine. A relation between the expression of fucolipids of epithelial cells and the ABO, Le and Se phenotype of the donor. J Biol Chem (1987) 1.67

Detection, localization, and quantitation of HIV-associated antigens in intestinal biopsies from patients with HIV. Am J Pathol (1991) 1.66

Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes. J Exp Med (1989) 1.60

Isolation of human T-lymphotropic retrovirus (LAV) from Zairian married couple, one with AIDS, one with prodromes. Lancet (1984) 1.51

Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells. J Virol (1992) 1.50

Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells. Proc Natl Acad Sci U S A (1991) 1.27

Characterization of human immunodeficiency virus type 1 strains recovered from the bowel of infected individuals. Virology (1991) 1.26

Human immunodeficiency virus infection of enterocytes and mononuclear cells in human jejunal mucosa. Gastroenterology (1991) 1.23

Human colon epithelial cells productively infected with human immunodeficiency virus show impaired differentiation and altered secretion. J Virol (1992) 1.13

Spontaneous and induced dome formation by two clonal cell populations derived from a human adenocarcinoma cell line, HT29. J Cell Sci (1986) 1.12

Glycosphingolipids of human large intestine: detailed structural characterization with special reference to blood group compounds and bacterial receptor structures. J Biochem (1991) 1.12

Infection of human gastrointestinal cells by HIV-1. AIDS Res Hum Retroviruses (1990) 1.11

HIV-1 infection and expression in human colonic cells: infection and expression in CD4+ and CD4- cell lines. AIDS (1991) 1.08

Replication and apical budding of HIV-1 in mucous-secreting colonic epithelial cells. J Acquir Immune Defic Syndr (1992) 0.96

Gastrointestinal symptoms in patients infected with human immunodeficiency virus: relevance of infective agents isolated from gastrointestinal tract. Gut (1992) 0.91

Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells. Cancer Res (1992) 0.90

Combination of culture on collagen gels and glucose starvation for cloning human colon cancer cells. Obtention of clones exhibiting different patterns of enterocytic differentiation. Cytotechnology (1991) 0.80

Articles by these authors

Using patient and general practice characteristics to explain variations in cervical smear uptake rates. BMJ (1994) 9.81

British Regional Heart Study: geographic variations in cardiovascular mortality, and the role of water quality. Br Med J (1980) 5.56

Prevalence of ischaemic heart disease in middle aged British men. Br Heart J (1984) 5.41

An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol (1992) 4.85

Social class differences in ischaemic heart disease in British men. Lancet (1987) 4.09

Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature (1972) 4.08

Using data from the 1991 census. BMJ (1995) 3.63

Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence. Nature (1985) 3.53

Home visiting by general practitioners in England and Wales. BMJ (1996) 3.31

Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types. J Exp Med (1989) 3.22

Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax (1998) 3.19

Cardiovascular risk factors in British children from towns with widely differing adult cardiovascular mortality. BMJ (1996) 3.14

Loss of employment and mortality. BMJ (1994) 3.06

Health of unemployed middle-aged men in Great Britain. Lancet (1982) 2.94

Early influences on blood pressure: a study of children aged 5-7 years. BMJ (1989) 2.90

Sociodemographic variables for general practices: use of census data. BMJ (1995) 2.90

Performance of a new pubertal self-assessment questionnaire: a preliminary study. Paediatr Perinat Epidemiol (2001) 2.85

CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J Virol (1989) 2.77

Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science (1991) 2.77

Reliability of eliciting physical signs in examination of the chest. Lancet (1988) 2.71

Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers. J Exp Med (1972) 2.68

Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. Proc Natl Acad Sci U S A (1989) 2.66

Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart (1997) 2.65

Seasonality and the requirements for perpetuation and eradication of viruses in populations. Am J Epidemiol (1979) 2.58

Recall of diagnosis by men with ischaemic heart disease. Br Heart J (1984) 2.57

Explaining variation in hospital admission rates between general practices: cross sectional study. BMJ (1999) 2.56

Blood pressure in British children: associations with adult blood pressure and cardiovascular mortality. Lancet (1988) 2.51

Size at birth and blood pressure: cross sectional study in 8-11 year old children. BMJ (1997) 2.45

Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology (1992) 2.41

Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice. J Exp Med (1972) 2.37

Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax (1997) 2.36

Children's exposure to passive smoking in England since the 1980s: cotinine evidence from population surveys. BMJ (2000) 2.28

Regression of area mortality rates on explanatory variables: what weighting is appropriate? J R Stat Soc Ser C Appl Stat (1981) 2.26

Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart (2005) 2.24

Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet (1989) 2.23

Evolution of statin prescribing 1994-2001: a case of agism but not of sexism? Heart (2003) 2.20

Giving up smoking and the risk of heart attacks. A report from The British Regional Heart Study. Lancet (1986) 2.19

Potentiation of experimental arbovirus encephalitis by immunosuppressive doses of cyclophosphamide. Nature (1968) 2.16

What factors are associated with physical activity in older people, assessed objectively by accelerometry? Br J Sports Med (2008) 2.07

Is body mass index before middle age related to coronary heart disease risk in later life? Evidence from observational studies. Int J Obes (Lond) (2009) 2.05

Is the clinical trial evidence about new drugs statistically adequate? Br J Clin Pharmacol (1985) 2.01

The genetics of susceptibility to multiple sclerosis. Epidemiol Rev (1982) 2.00

Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation. J Virol (1997) 1.98

Use of statins in the secondary prevention of coronary heart disease: is treatment equitable? Heart (2002) 1.98

Chronic exposure to outdoor air pollution and lung function in adults. Thorax (2009) 1.98

Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studies. Lab Invest (1976) 1.96

A critical review of the effect of factory closures on health. Br J Ind Med (1991) 1.95

The amino acid at the X position of an Asn-X-Ser sequon is an important determinant of N-linked core-glycosylation efficiency. J Biol Chem (1996) 1.90

Trends in secondary prevention of ischaemic heart disease in the UK 1994 2005: use of individual and combination treatment. Heart (2007) 1.87

The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. Am J Epidemiol (1979) 1.87

Age of menarche in contemporary British teenagers: survey of girls born between 1982 and 1986. BMJ (2001) 1.81

Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1991) 1.80

Immunosuppression and experimental virus infection of the nervous system. Adv Virus Res (1970) 1.79

Human exposure to SV40: review and comment. Am J Epidemiol (1976) 1.77

The Dinamap 1846SX automated blood pressure recorder: comparison with the Hawksley random zero sphygmomanometer under field conditions. J Epidemiol Community Health (1992) 1.77

ABO blood group and ischaemic heart disease in British men. BMJ (1990) 1.76

The effects of adiposity and weight change on forced expiratory volume decline in a longitudinal study of adults. Int J Obes Relat Metab Disord (1999) 1.72

Non-employment and changes in smoking, drinking, and body weight. BMJ (1992) 1.68

Lymphocytic choriomeningitis virus: pathogenesis of acute central nervous system disease. Fed Proc (1972) 1.66

Do maternal and intrauterine factors influence blood pressure in childhood? Arch Dis Child (1992) 1.66

Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol (1990) 1.65

The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency. Biochemistry (1998) 1.65

Fatal Japanese encephalitis virus infection in immunosuppresed spider monkeys. Clin Exp Immunol (1970) 1.61

Chronic manganese intoxication. Arch Neurol (1974) 1.61

The effect of soft cervical collars on persistent neck pain in patients with whiplash injury. Acad Emerg Med (1996) 1.61

Health and social precursors of unemployment in young men in Great Britain. J Epidemiol Community Health (1996) 1.60

Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection. Am J Epidemiol (1982) 1.60

Passive smoking and sudden infant death syndrome: review of the epidemiological evidence. Thorax (1997) 1.55

Time trends in respiratory symptoms in childhood over a 24 year period. Arch Dis Child (1993) 1.55

Flow-mediated dilation in 9- to 11-year-old children: the influence of intrauterine and childhood factors. Circulation (1997) 1.54

Cholesterol and arterial distensibility in the first decade of life: a population-based study. Circulation (2000) 1.53

Infections presenting for clinical care in early life and later risk of hay fever in two UK birth cohorts. Allergy (2008) 1.52

Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors. J Infect Dis (1974) 1.51

Induction of apoptosis by La Crosse virus infection and role of neuronal differentiation and human bcl-2 expression in its prevention. J Virol (1996) 1.50

Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J (1986) 1.49

Lymphocytic choriomeningitis. Pathogenesis. Prog Med Virol (1974) 1.47

Central nervous system immunity in mice infected with theiler's virus. I. Local neutralizing antibody response. J Infect Dis (1978) 1.46

Socio-economic determinants of casualty and NHS Direct use. J Public Health (Oxf) (2008) 1.46

British South Asians aged 13-16 years have higher fasting glucose and insulin levels than Europeans. Diabet Med (2005) 1.46

D-penicillamine treatment improves survival in primary biliary cirrhosis. Lancet (1981) 1.45

Timing of routine immunisations and subsequent hay fever risk. Arch Dis Child (2005) 1.45

Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus. Lab Invest (1984) 1.44

Do children who become autistic consult more often after MMR vaccination? Br J Gen Pract (2001) 1.44

Annual night visiting rates in 129 general practices in one family health services authority: association with patient and general practice characteristics. Br J Gen Pract (1995) 1.43

Experimental infection of monkeys with Langat virus II. Turnover of circulating virus, 1967. Rev Med Virol (2000) 1.42

Pathogenesis of visna. II. Effect of immunosuppression upon early central nervous system lesions. Lab Invest (1976) 1.42

Eradication of poliomyelitis in the United States. Rev Infect Dis (1983) 1.42

Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet (1998) 1.42

Unemployment pre-dates symptoms of depression and anxiety resulting in medical consultation in young men. Int J Epidemiol (1999) 1.40

Arterial distensibility in adolescents: the influence of adiposity, the metabolic syndrome, and classic risk factors. Circulation (2005) 1.37

Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeat. J Virol (1993) 1.37

Health effects of passive smoking .5. Parental smoking and allergic sensitisation in children. Thorax (1998) 1.35

Experimental encephalitis following peripheral inoculation of West Nile virus in mice of different ages. J Hyg (Lond) (1970) 1.34

Short stature, lung function and risk of a heart attack. Int J Epidemiol (1989) 1.33

Effects of changes in fresh fruit consumption on ventilatory function in healthy British adults. Am J Respir Crit Care Med (1998) 1.33

Non-participation and mortality in a prospective study of cardiovascular disease. J Epidemiol Community Health (1987) 1.32